Anna Abolian

Anna Abolian


Job title: Medical Director, Clinical Development


Workshop A: Unlocking the Potential of the Suprachoroidal Space to Deliver Durable Ophthalmic Therapies 9:00 am - 12:00 pm

Suprachoroidal delivery is an emerging and exciting alternative administration route to increase the durability of different ophthalmic therapies. The recent FDA approval of the first therapeutic delivered into the suprachoroidal space is leading the charge of an array of ongoing preclinical and clinical developments using suprachoroidal delivery for a range of ophthalmic modalities and indications.…Read more

day: Pre-Conference Workshop Day

Assessing Current Clinical Developments in Ophthalmic AAV Vector Gene Therapies Delivered by Subretinal and Suprachoroidal Injection 10:45 am

Exploring the technological background of therapies in development Evaluating the progress of ongoing clinical trials Addressing existing unmet clinical needs in target disease areasRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.